| |
| |
 |
This week in First Opinion, authors countered the false narrative that Covid-19 has become a "racial equity success story," argued for better, safer treatments for pediatric cancers, and more. The 2022 STAT Summit takes place in a couple weeks; check out the speakers and agenda here. |
| |
| By Marina Del Rios and Nathan T. Chomilo and Neil A. Lewis, Jr. Scott Olson/Getty Images Improved vaccination rates in Black and Hispanic communities is important. But it doesn't translate into a racial equity success story. Read More |
| By Gwen Nichols Adobe Treatments for pediatric cancer can come at a steep physical and mental cost. Kids need treatments that are less toxic in the long run. Read More |
| By Kathleen Bachynski Adobe Stock The Concussion in Sport Group publishes the "bible" of concussion recommendations. Its process needs more transparency and oversight. Read More |
| Sponsored Insight by Phlow The true costs of foreign API and the domestic CDMO solution More than 80% of the active pharmaceutical ingredients used to manufacture today's vital medications are produced abroad. But what is the true cost of relinquishing control of the supply of our Nation's essential medicines to foreign sources? By collaborating with a variety of pharmaceutical and biotech companies, Phlow provides expert consultation and differentiated R&D services, through their SMART-CDMO, in an effort to re-shore the manufacturing of essential and innovative medicines for good. Learn more. |
| By Patrick Skerrett Medicare has proposed deep cuts to home health care and clawbacks to care provided during the pandemic, when it was needed the most. Read More |
| By Neel Vahil Andrew Selsky/AP In the very early days of the pandemic, keeping family members out of ICUs made sense. But those days are over, and their presence is needed. Read More |
| By John Michael O'Brien Adobe Stock The 340B Drug Discount Program is now a giant federal program. But it's impossible to tell where the money is going. That needs to change. Read More |
| By Sarah Smithson Alberto Pizzoli/AFP via Getty Images Motivational interviewing helps determine if it's time to take action. It needs to be applied to improving health care workers' well-being. Read More |
| By Meg Richards Naomi Baker/Getty Images Whether a company must rely on regulatory grade evidence depends on if it plans to use the data publicly or privately. Read More |
| By Linda Richter and Diana Fishbein States need to resist allocating opioid settlement funds for law enforcement and other measures and toward real solutions for addiction. Read More |
| By Linda Goler Blount YASUYOSHI CHIBA/AFP via Getty Images Medicare's coverage for PET scans for brain amyloid protein, a sign of Alzheimer's disease, falls short, especially for Black Americans. Read More |
No comments